Significant reduction of insulin dose after administration of sacubitril/valsartan in the patient with heart failure due to dilated cardiomyopathy, a case report.
25 May 2019 (08:30 - 17:30)
Organised by:
Abstract
Slides
About the speaker
Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
28 More presentations in this session
Access the full session
The Event
Heart Failure 2019
25 May 2019
08:30 CET
You may be interested in
Congress Presentation
